STOCK TITAN

Kura Oncology officer plans $36.5K stock sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Kura Oncology, Inc. (KURA) officer Thomas James Doyle reported a planned sale of 4,697 shares of common stock, with an aggregate market value of $36,495.69 and an approximate sale date of November 16, 2026. The notice identifies the shares as acquired from the issuer on November 13, 2026, in a transaction designated “PSU.”

Planned shares for sale 4,697 shares Kura Oncology common stock; approximate sale date November 16, 2026
Aggregate market value $36,495.69 Shares listed for planned sale
Approximate sale date November 16, 2026 Planned sale of 4,697 common shares
Prior shares sold 4,607 shares Performance-based restricted stock units sold September 28, 2026
Prior gross proceeds $48,360.60 Sale of performance-based restricted stock units on September 28, 2026
Shares outstanding 92,784,785 shares Issuer share count listed in the securities information
PSU technical
"Nature of Acquisition Transaction: PSU"
A PSU is a company where the government owns a controlling stake and often plays a direct role in its management and strategy. Think of it like a business that operates with public oversight, similar to a town-run utility versus a private neighborhood service. Investors watch PSUs differently because government involvement can affect profits, dividend policies, regulatory treatment and stability, so these stocks may behave more like policy instruments than pure market-driven enterprises.
Performance-Based Restricted Stock Units technical
"Title of Securities Sold: Performance-Based Restricted Stock Units"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
Sell-to-cover financial
"Gross Proceeds Sell-to-cover for Thomas Doyle"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KURA shares did officer Thomas James Doyle plan to sell?

Thomas James Doyle reported a planned sale of 4,697 shares of common stock, with an aggregate market value of $36,495.69 and an approximate sale date of November 16, 2026.

What earlier KURA share sale does the notice list for Thomas James Doyle?

The notice lists 4,607 performance-based restricted stock units sold on September 28, 2026, for gross proceeds of $48,360.60.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading